0001878961-22-000001.txt : 20220707
0001878961-22-000001.hdr.sgml : 20220707
20220707163629
ACCESSION NUMBER: 0001878961-22-000001
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220707
DATE AS OF CHANGE: 20220707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Glen R.
CENTRAL INDEX KEY: 0001878961
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 221072034
MAIL ADDRESS:
STREET 1: 3274 ROSS ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 347-480-9760
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2022-06-27
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001878961
Anderson Glen R.
101 SOUTH 200 EAST, SUITE 700
SALT LAKE CITY
UT
84111
0
0
1
0
Common Stock
113918
D
Common Stock
973130
I
By Anderson Family Trust u/a dtd 01/07/2018
(1) On June 27, 2022, Reporting Person acquired 19,467 shares of common stock at $2.06 per share, resulting in total beneficial ownership as of June 27, 2022, of 844,970 shares of common stock or 10.23% of the outstanding common stock. Since June 27, 2022, Reporting Person has made the following purchases in the market: 61,360 shares at $2.22 per share on 6/28/2022; 57,620 shares at $2.39 per share on 6/29/2022; 79,400 shares at $2.99 per share on 7/1/2022; and 43,698 shares at $3.09 per share on 7/5/2022, for a total beneficial ownership of 1,087,048 shares of common stock as of July 5, 2022 or 13.16% of the outstanding common stock.
Glen R. Anderson
2022-07-07